Gold Prices Hold The Line Amid Stock Market Breakout
The prices for gold and other precious metals held the line on Thursday, breaking above the $1,500 mark for the first time since November. Though the broader markets and global stocks saw fresh, all-time highs, there is still uncertainty abound.
Pharma Stocks Making Big Moves in December
One of the sectors that has proved to be a treasure trove for stock investors over the course of the past decade or so is the biotech sector. Investors have managed to create a lot of wealth during this period by investing in a wide range of biotech stocks. Which stocks performed well this month?
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Lynparza® (olaparib) In Patients with Germline BRCA-mutated Metastatic Pancreatic Cancer
Myriad Genetics, Inc. (MYGN), a leader in molecular diagnostics and precision medicine, today announced that the U.S. Food and Drug Administration (FDA) has approved BRACAnalysis CDx® for use as a companion diagnostic test by healthcare professionals to identify patients with metastatic pancreatic cancer who have a germline BRCA mutation and are candidates for treatment with PARP inhibitor Lynparza® (olaparib).